Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atypical Lobular Hyperplasia (ALH) of Breast”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Not applicableUnknownNCT05868252
What this trial is testing

Molecular Analysis of the Sloane Project

Who this might be right for
DCISLCISAtypical Ductal Hyperplasia+1 more
King's College London 1,500
Not applicableUnknownNCT01034891
What this trial is testing

Women At Risk: The High Risk Breast Cancer Program

Who this might be right for
Breast Cancer
New York Presbyterian Hospital 2,000
Early research (Phase 1)Study completedNCT01372644
What this trial is testing

Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor: A Proof of Principle Trial

Who this might be right for
Atypical Ductal Breast HyperplasiaLobular Carcinoma in Situ (LCIS)Atypical Lobular Hyperplasia (ALH) of Breast
NYU Langone Health 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07499999
What this trial is testing

Randomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at High Risk for Breast Cancer

Who this might be right for
Breast CancerDuctal CarcinomaEstrogen-receptor-positive Breast Cancer+4 more
Dana-Farber Cancer Institute 140
Not applicableStudy completedNCT00620087
What this trial is testing

Molecular Breast Imaging in Women With Atypia and LCIS

Who this might be right for
Atypical Lobular HyperplasiaAtypical Ductal HyperplasiaLobular Carcinoma in Situ
Mayo Clinic 66
Not applicableStudy completedNCT00146536
What this trial is testing

Upstaging of ALH/LCIS Found on Core Biopsy Based on Subsequent Excisional Biopsy

Who this might be right for
Breast Neoplasms
Dana-Farber Cancer Institute 78
Not applicableWithdrawnNCT03868475
What this trial is testing

Comparing Vacuum-Assisted Percutaneous Excision to Open Surgical Excision for Borderline or High-Risk Breast Lesions

Who this might be right for
Breast FibroadenomaAtypical Ductal HyperplasiaAtypical Lobular Hyperplasia+7 more
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Testing effectiveness (Phase 2)Ended earlyNCT04570956
What this trial is testing

Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia, Lobular Carcinoma In Situ, or Increased Breast Cancer Risk

Who this might be right for
Breast Atypical HyperplasiaBreast Lobular Carcinoma in SituBreast Atypical Lobular Hyperplasia+1 more
Mayo Clinic 65
Early research (Phase 1)Study completedNCT03323658
What this trial is testing

Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer

Who this might be right for
Breast Atypical Ductal HyperplasiaBreast Atypical Lobular HyperplasiaBreast Ductal Carcinoma In Situ+2 more
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT02928978
What this trial is testing

Ruxolitinib for Premalignant Breast Disease

Who this might be right for
Ductal Carcinoma In SituAtypical Lobular HyperplasiaAtypical Ductal Hyperplasia+1 more
Julie Nangia 84
Not applicableLooking for participantsNCT05178498
What this trial is testing

Impact of Dietary Inflammatory Potential on Breast Cancer Risk

Who this might be right for
Breast Atypical Ductal HyperplasiaBreast Atypical Lobular HyperplasiaBreast Carcinoma+2 more
Ohio State University Comprehensive Cancer Center 960